Target intelligence / Profile preview

CDC42 pseudogene 3 (CDC42P3)

Target
CDC42P3
Molecular classification
Other (pseudogene; not a protein-coding gene. It does not belong to functional molecular families such as G protein-coupled receptors, ion channels, enzymes, etc.)
01

Overview

CDC42 pseudogene 3 (CDC42P3) is a non-protein-coding genomic sequence homologous to the CDC42 gene. As a pseudogene, it does not produce a functional protein and is not considered a therapeutic target. Its presence is typically of genetic or evolutionary interest. There is no evidence for biological function, disease relevance, or drug interaction related to CDC42P3[2][4].

Other names
CDC42P3CDC42 pseudogene 3

Beyond the preview

Go deeper on CDC42 pseudogene 3 (CDC42P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDC42 pseudogene 3 (CDC42P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call